Sec Form 13D Filing - Aleksandar Milovanovic filing for - 2025-06-02

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
(7),(9),(11) Includes 850 shares of common stock issuable upon conversion of 850 shares of Series C Voting Preferred Stock held by Mr. Milovanović. 
 (7),(11) When including the voting rights of the 850 shares of Series C Voting Preferred Stock held by Mr. Milovanović, which each vote 7,500 voting shares, or 6,375,000 voting shares in aggregate, such shares would total 91,083,663.
 (13) When including all voting shares of the Issuer outstanding and the voting rights of the 850 shares of Series C Voting Preferred Stock held by Mr. Milovanović, which each vote 7,500 voting shares, or 6,375,000 voting shares in aggregate, such voting percentage would total 59.3%. Based solely for the purposes of such calculation on a total of 153,591,616 total voting shares including 138,591,616 total common shares, the number of shares outstanding as of May 30, 2025, as confirmed by the Issuer's Transfer Agent, 7,500,000 shares voted by the Series B Voting Preferred Stock and 7,500,000 shares voted by the Series C Voting Preferred Stock.
 (13) Based solely for the purposes of such calculation on 138,591,616 total common shares, the number of shares outstanding as of May 30, 2025, as confirmed by the Issuer's Transfer Agent.
 (7),(9),(11),(13) Does not include shares of Common Stock held by the other Group Members (as defined below in Item 2). The Reporting Persons (as defined below in Item 2) believe that they and the other Group Members together as a "group" may be deemed to collectively beneficially own in the aggregate 105,790,540 total vot ing shares or 68.9% of the Issuer's total voting shares, as of May 30, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
(7),(9),(11) Includes 100 shares of common stock issuable upon conversion of 100 shares of Series C Voting Preferred Stock held by the Reporting Person. 
 (7),(11) When including the voting rights of the 100 shares of Series C Voting Preferred Stock held by the Reporting Person, which each vote 7,500 voting shares, or 750,000 voting shares in aggregate, such shares would total 9,807,664.
 (13) When including all voting shares of the Issuer outstanding and the voting rights of the 100 shares of Series C Voting Preferred Stock held by the Reporting Person, which each vote 7,500 voting shares, or 750,000 voting shares in aggregate, such voting percentage would total 6.4%. Based solely for the purposes of such calculation on a total of 153,591,616 total voting shares including 138,591,616 total common shares, the number of shares outstanding as of May 30, 2025, as confirmed by the Issuer's Transfer Agent, 7,500,000 shares voted by the Series B Voting Preferred Stock and 7,500,000 shares voted by the Series C Voting Preferred Stock.
 (13) Based solely for the purposes of such calculation on 138,591,616 total common shares, the number of shares outstanding as of May 30, 2025, as confirmed by the Issuer's Transfer Agent.
 (7),(9),(11),(13) Does not include shares of Common Stock held by the other Group Members (as defined below in Item 2). The Reporting Persons (as defined below in Item 2) believe that they and the other Group Members together as a "group" may be deemed to collectively beneficially own in the aggregate 105,790,540 total voting shares or 68.9% of the Issuer's total voting shares, as of May 30, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
(7),(9),(11) Includes 50 shares of common stock issuable upon conversion of 50 shares of Series C Voting Preferred Stock held by the Reporting Person. 
 (7),(11) When including the voting rights of the 50 shares of Series C Voting Preferred Stock held by the Reporting Person, which each vote 7,500 voting shares, or 375,000 voting shares in aggregate, such shares would total 4,899,213.
 (13) When including all voting shares of the Issuer outstanding and the voting rights of the 50 shares of Series C Voting Preferred Stock held by the Reporting Person, which each vote 7,500 voting shares, or 375,000 voting shares in aggregate, such voting percentage would total 3.2%. Based solely for the purposes of such calculation on a total of 153,591,616 total voting shares including 138,591,616 total common shares, the number of shares outstanding as of May 30, 2025, as confirmed by the Issuer's Transfer Agent, 7,500,000 shares voted by the Series B Voting Preferred Stock and 7,500,000 shares voted by the Series C Voting Preferred Stock.
 (13) Based solely for the purposes of such calculation on 138,591,616 total common shares, the number of shares outstanding as of May 30, 2025, as confirmed by the Issuer's Transfer Agent.
 (7),(9),(11),(13) Does not include shares of Common Stock held by the other Group Members (as defined below in Item 2). The Reporting Persons (as defined below in Item 2) believe that they and the other Group Members together as a "group" may be deemed to collectively beneficially own in the aggregate 105,790,540 total voting shares or 68.9% of the Issuer's total voting shares, as of May 30, 2025.


SCHEDULE 13D

 
Aleksandar Milovanovic
 
Signature:/s/ Aleksandar Milovanovic
Name/Title:Aleksandar Milovanovic
Date:06/02/2025
 
Zoran Milosevic
 
Signature:/s/ Zoran Milosevic
Name/Title:Zoran Milosevic
Date:06/02/2025
 
Snezana Bozovic
 
Signature:/s/ Snezana Bozovic
Name/Title:Snezana Bozovic
Date:06/02/2025
primary_doc.xml